{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:19:33Z","timestamp":1785521973122,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["grant nos.82070341"],"award-info":[{"award-number":["grant nos.82070341"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["grant nos. 2023J011189"],"award-info":[{"award-number":["grant nos. 2023J011189"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major Project of Fujian Provincial Joint Funds for Science and Technology Innovation","award":["grant nos. 2023Y96030242"],"award-info":[{"award-number":["grant nos. 2023Y96030242"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although cardiovascular disease (CVD) frequently co-occurs with lung cancer and adversely affects prognosis, the temporal patterns of CVD mortality in this patient group remain inadequately explored. We aimed to clarify trends and disparities in CVD mortality among United States (US) adults with lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Utilizing the Centers for Disease Control and Prevention\u2019s Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) spanning from 1999 to 2023 for adults aged 35 years and older, we calculated age-adjusted mortality rates (AAMRs) and crude mortality rates (CMRs) per 100,000 individuals, with the AAMRs standardized to the 2000 US population. The annual percent change (APC) and average annual percent change (AAPC) were estimated using joinpoint regression analysis. In CDC WONDER, the National Center for Health Statistics assigns the underlying cause of death using standardized World Health Organization rules. Thus, we defined CVD as the underlying cause of death and lung cancer as a contributing cause based on the database\u2019s coding framework rather than investigator judgment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 93,859 CVD deaths in lung cancer patients, mortality declined significantly from 1999 to 2015 (APC: \u2212\u20094.70), but increased in females from 2015 to 2023 (APC: 1.73), while remaining stable in males (APC: 0.44). Males experienced a more pronounced reduction in AAMRs, decreasing from 5.39 in 1999 to 2.24 in 2023, but consistently had higher CVD mortality rates than females. During most of the study period, Non-Hispanic African American or Black (NH Black) individuals experienced the highest AAMRs, followed by NH Whites. Long-term decline in CVD mortality reversed significantly among individuals aged\u2009\u2265\u200985 years since 2017. Significant differences in AAPC relative to the general population were identified among the Northeast, NH Black, NH White, males, and across all age groups except for the 75\u201384 cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although CVD mortality in the US declined from 1999 to 2023, this trend has stalled or reversed among adults with lung cancer since 2015. Ongoing disparities by sex, race, age, region, and state emphasize the urgent need for targeted interventions for these vulnerable groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40959-026-00512-z","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T03:36:17Z","timestamp":1779420977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in cardiovascular mortality among lung cancer patients in the United States: a retrospective study from 1999 to 2023"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4690-7531","authenticated-orcid":false,"given":"Yong-li","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-quan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-wen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3613-4476","authenticated-orcid":false,"given":"Xiao\u2010xia","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-nan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2988-1433","authenticated-orcid":false,"given":"Re\u2010hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8848-5748","authenticated-orcid":false,"given":"Jian\u2010cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"512_CR1","doi-asserted-by":"publisher","first-page":"e1096","DOI":"10.1161\/CIR.0000000000001345","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, et al. Correction to: 2025 heart disease and stroke statistics: a report of US and global data from the american heart association. Circulation. 2025;151:e1096. https:\/\/doi.org\/10.1161\/CIR.0000000000001345.","journal-title":"Circulation"},{"key":"512_CR2","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1097\/CM9.0000000000003442","volume":"137","author":"YJ Wu","year":"2024","unstructured":"Wu YJ, He SY, Cao MD, Teng Y, Li QR, Tan NP, et al. Comparative analysis of cancer statistics in China and the United States in 2024. Chin Med J (Engl). 2024;137:3093\u2013100. https:\/\/doi.org\/10.1097\/CM9.0000000000003442.","journal-title":"Chin Med J (Engl)"},{"key":"512_CR3","doi-asserted-by":"publisher","first-page":"1258991","DOI":"10.3389\/fonc.2024.1258991","volume":"14","author":"M de Jesus","year":"2024","unstructured":"de Jesus M, Chanda ANDT, Grabauskas T, Kumar M, Kim AS. Cardiovascular disease and lung cancer. Front Oncol. 2024;14:1258991. https:\/\/doi.org\/10.3389\/fonc.2024.1258991.","journal-title":"Front Oncol"},{"key":"512_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jaccao.2025.05.003","volume":"7","author":"M El-Rayes","year":"2025","unstructured":"El-Rayes M, Nardi Agmon I, Yu C, Osataphan N, Yu HA, Hope A, et al. Lung cancer and cardiovascular disease: common pathophysiology and treatment-emergent toxicity. JACC CardioOncology. 2025;7:325\u201344. https:\/\/doi.org\/10.1016\/j.jaccao.2025.05.003.","journal-title":"JACC CardioOncology"},{"key":"512_CR5","doi-asserted-by":"publisher","first-page":"950971","DOI":"10.3389\/fonc.2022.950971","volume":"12","author":"C Wang","year":"2022","unstructured":"Wang C, Lu DH, Cronin-Fenton D, Huang C, Liew Z, Wei D, et al. Cardiovascular disease and risk of lung cancer incidence and mortality: a nationwide matched cohort study. Front Oncol Front. 2022;12:950971. https:\/\/doi.org\/10.3389\/fonc.2022.950971.","journal-title":"Front Oncol Front"},{"key":"512_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nrclinonc.2014.235","volume":"12","author":"L Hutchinson","year":"2015","unstructured":"Hutchinson L. Targeted therapies: new standard for ALK-positive NSCLC. Nat Rev Clin Oncol. 2015;12:66. https:\/\/doi.org\/10.1038\/nrclinonc.2014.235.","journal-title":"Nat Rev Clin Oncol"},{"key":"512_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-017-0456-5","volume":"10","author":"A Somasundaram","year":"2017","unstructured":"Somasundaram A, Burns TF. The next generation of immunotherapy: keeping lung cancer in check. J Hematol Oncol. 2017;10:87. https:\/\/doi.org\/10.1186\/s13045-017-0456-5.","journal-title":"J Hematol Oncol"},{"key":"512_CR8","doi-asserted-by":"publisher","first-page":"116713","DOI":"10.1016\/j.lfs.2019.116713","volume":"233","author":"H Memon","year":"2019","unstructured":"Memon H, Patel BM. Immune checkpoint inhibitors in non-small cell lung cancer: a bird\u2019s eye view. Life Sci. 2019;233:116713. https:\/\/doi.org\/10.1016\/j.lfs.2019.116713.","journal-title":"Life Sci"},{"key":"512_CR9","doi-asserted-by":"publisher","first-page":"e007307","DOI":"10.1136\/jitc-2023-007307","volume":"11","author":"ZD Drobni","year":"2023","unstructured":"Drobni ZD, Gongora C, Taron J, Suero-Abreu GA, Karady J, Gilman HK, et al. Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer. J ImmunoTher Cancer. 2023;11:e007307. https:\/\/doi.org\/10.1136\/jitc-2023-007307.","journal-title":"J ImmunoTher Cancer"},{"key":"512_CR10","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/ejhf.3340","volume":"26","author":"CG Tocchetti","year":"2024","unstructured":"Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, et al. Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the heart failure association (HFA) of the ESC and the ESC council of cardio-oncology. Eur J Heart Fail. 2024;26:2055\u201376. https:\/\/doi.org\/10.1002\/ejhf.3340.","journal-title":"Eur J Heart Fail"},{"key":"512_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12931-025-03344-0","volume":"26","author":"T Billion","year":"2025","unstructured":"Billion T, Verheyen L, Abdul Jabbar AB, Asghar N, Mirza M, Mirza M, et al. Regional trends and disparities of lung cancer mortality in the United States, 1999\u20132022: a retrospective cohort study. Respir Res. 2025;26:280. https:\/\/doi.org\/10.1186\/s12931-025-03344-0.","journal-title":"Respir Res"},{"key":"512_CR12","doi-asserted-by":"publisher","first-page":"e038644","DOI":"10.1161\/JAHA.124.038644","volume":"14","author":"SJ King","year":"2025","unstructured":"King SJ, Wangdak Yuthok TY, Bacong AM, Khandelwal A, Kazi DS, Mussolino ME, et al. Heart disease mortality in the United States, 1970 to 2022. J Am Heart Assoc. 2025;14:e038644. https:\/\/doi.org\/10.1161\/JAHA.124.038644.","journal-title":"J Am Heart Assoc"},{"key":"512_CR13","doi-asserted-by":"publisher","unstructured":"Hashemian M, Roger VL. Understanding cardiovascular mortality: a deep dive into the differences between GBD and CDC WONDER. Circ: Cardiovasc Qual Outcomes. 2025;18:e011926. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.125.011926","DOI":"10.1161\/CIRCOUTCOMES.125.011926"},{"key":"512_CR14","doi-asserted-by":"publisher","first-page":"200377","DOI":"10.1016\/j.ijcrp.2025.200377","volume":"24","author":"EM Ali","year":"2025","unstructured":"Ali EM, Ur Rahman HA, Kamal UH, Ali Fahim MA, Salman M, Salman A, et al. Trends and regional variations in chronic ischemic heart disease and lung cancer-related mortality among american adults: insights from retrospective CDC wonder analysis. Int J Cardiol Cardiovasc Risk Prev. 2025;24:200377. https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200377.","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"512_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.122.060199","volume":"146","author":"AN Kyalwazi","year":"2022","unstructured":"Kyalwazi AN, Loccoh EC, Brewer LC, Ofili EO, Xu JM, Song Y, et al. Disparities in cardiovascular mortality between black and white adults in the United States, 1999 to 2019. Circulation. 2022;146:211\u201328. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.060199.","journal-title":"Circulation"},{"key":"512_CR16","doi-asserted-by":"publisher","unstructured":"Alim Ur Rahman H, Ahmed Ali Fahim M, Salman A, Kumar S, Raja A, Raja S et al. Investigating sex, race, and geographic disparities in bronchus and lung cancer mortality in the United States: a comprehensive longitudinal study (1999\u20132020) utilizing CDC WONDER data. Ann Med Surg (2012). 2024;86:5361\u20139. https:\/\/doi.org\/10.1097\/MS9.0000000000002387","DOI":"10.1097\/MS9.0000000000002387"},{"key":"512_CR17","doi-asserted-by":"publisher","first-page":"102652","DOI":"10.1016\/j.canep.2024.102652","volume":"92","author":"S Soin","year":"2024","unstructured":"Soin S, Ibrahim R, Wig R, Mahmood N, Pham HN, Sainbayar E, et al. Lung cancer mortality trends and disparities: a cross-sectional analysis 1999\u20132020. Cancer Epidemiol. 2024;92:102652. https:\/\/doi.org\/10.1016\/j.canep.2024.102652.","journal-title":"Cancer Epidemiol"},{"key":"512_CR18","unstructured":"ICD10Data.com. The web\u2019s free 2019 ICD-10-CM\/PCS medical coding reference. Icd10data.com; 2019 [Internet]. https:\/\/www.icd10data.com\/"},{"key":"512_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"key":"512_CR20","unstructured":"Geographic division or region - health, united states. July 30). Cdc.gov. https:\/\/www.cdc.gov\/nchs\/hus\/sources-definitions\/geographic-region.htm; 2024. Accessed 2 Oct 2025."},{"key":"512_CR21","unstructured":"Underlying cause of. death 1999\u20132020. Cdc.gov. https:\/\/wonder.cdc.gov\/wonder\/help\/ucd.html; 2020. Accessed 9 Oct 2025."},{"key":"512_CR22","unstructured":"Joinpoint regression program [computer software]. Version 5.1.0.0. statistical research and applications branch. National cancer institute; 2024."},{"issue":"20000215","key":"512_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(sici)1097-0258","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(20000215):335\u201351. https:\/\/doi.org\/10.1002\/(sici)1097-0258. )19:3%3C335::aid-sim336%3E3.0.co;2-z.","journal-title":"Stat Med"},{"key":"512_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fendo.2018.00215","volume":"9","author":"Z-P Tang","year":"2018","unstructured":"Tang Z-P, Zhao W, Du J-K, Ni X, Zhu X-Y, Lu J-Q. miR-494 contributes to estrogen protection of cardiomyocytes against oxidative stress via targeting (NF-\u03baB) repressing factor. Front Endocrinol. 2018;9:215. https:\/\/doi.org\/10.3389\/fendo.2018.00215.","journal-title":"Front Endocrinol"},{"key":"512_CR25","doi-asserted-by":"publisher","first-page":"eabo1981","DOI":"10.1126\/scitranslmed.abo1981","volume":"14","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Sun C, Li Y, Qin J, Amancherla K, Jing Y, et al. Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis. Sci Transl Med. 2022;14:eabo1981. https:\/\/doi.org\/10.1126\/scitranslmed.abo1981.","journal-title":"Sci Transl Med"},{"key":"512_CR26","doi-asserted-by":"publisher","unstructured":"Sf C, G DCJNVC. K, A S, Sex-related differences in immunotherapy outcomes of patients with advanced non-small cell lung cancer. Current Oncology (Toronto, Ont) [Internet]. Curr Oncol; 2024;31. https:\/\/doi.org\/10.3390\/curroncol31110544.\u00a0\u00a0Cited 16 Apr 2026.","DOI":"10.3390\/curroncol31110544"},{"key":"512_CR27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02377","author":"U Jm","year":"2022","unstructured":"Jm U, Ks RV, Lm AML, Cc M. Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology [Internet]. J Clin Oncol. 2022. https:\/\/doi.org\/10.1200\/JCO.21.02377. [cited 2026 Apr 16];40.","journal-title":"J Clin Oncol"},{"key":"512_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1053\/j.seminoncol.2022.09.004","volume":"49","author":"L Pala","year":"2022","unstructured":"Pala L, De Pas T, Conforti F. Under-representation of women in randomized clinical trials testing anticancer immunotherapy may undermine female patients care. A call to action. Semin Oncol. 2022;49:400\u20134. https:\/\/doi.org\/10.1053\/j.seminoncol.2022.09.004.","journal-title":"Semin Oncol"},{"key":"512_CR29","doi-asserted-by":"publisher","first-page":"e2400008","DOI":"10.1200\/OA.24.00008","volume":"1","author":"D Yang","year":"2024","unstructured":"Yang D, Karanth SD, Yoon H-S, Yang JJ, Lou X, Bian J, et al. Disparities in utilization of immune checkpoint inhibitor therapy among older patients with advanced non\u2013small cell lung cancer: a SEER-medicare analysis. JCO Oncol Adv. 2024;1:e2400008. https:\/\/doi.org\/10.1200\/OA.24.00008.","journal-title":"JCO Oncol Adv"},{"key":"512_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3322\/caac.21874","volume":"75","author":"AH Saka","year":"2025","unstructured":"Saka AH, Giaquinto AN, McCullough LE, Tossas KY, Star J, Jemal A, et al. Cancer statistics for african american and black people, 2025. CA Cancer J Clin. 2025;75:111\u201340. https:\/\/doi.org\/10.3322\/caac.21874.","journal-title":"CA Cancer J Clin"},{"key":"512_CR31","doi-asserted-by":"publisher","unstructured":"ZCJ, STT, JCC, LBQ, BLA, ZS. Racial and ethnic disparities in all-cause and cardiovascular mortality among cancer patients in the U.S. JACC CardioOncology. 2023;5:55\u201366. https:\/\/doi.org\/10.1016\/j.jaccao.2022.10.013.","DOI":"10.1016\/j.jaccao.2022.10.013"},{"key":"512_CR32","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s11912-024-01578-7","volume":"26","author":"MC Tan","year":"2024","unstructured":"Tan MC, Stabellini N, Tan JY, Thong JY, Hedrick C, Moore JX, et al. Reducing racial and ethnic disparities in cardiovascular outcomes among cancer survivors. Curr Oncol Rep. 2024;26:1205\u201312. https:\/\/doi.org\/10.1007\/s11912-024-01578-7.","journal-title":"Curr Oncol Rep"},{"key":"512_CR33","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1161\/CIR.0000000000000534","volume":"136","author":"MR Carnethon","year":"2017","unstructured":"Carnethon MR, Pu J, Howard G, Albert MA, Anderson CAM, Bertoni AG, et al. Cardiovascular health in african americans: a scientific statement from the american heart association. Circulation. 2017;136:e393\u2013423. https:\/\/doi.org\/10.1161\/CIR.0000000000000534.","journal-title":"Circulation"},{"key":"512_CR34","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1161\/CIRCULATIONAHA.117.029652","volume":"137","author":"WM Schultz","year":"2018","unstructured":"Schultz WM, Kelli HM, Lisko JC, Varghese T, Shen J, Sandesara P, et al. Socioeconomic status and cardiovascular outcomes: challenges and interventions. Circulation. 2018;137:2166\u201378. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029652.","journal-title":"Circulation"},{"key":"512_CR35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3322\/caac.21577","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Miller KD, Dale W, Mohile SG, Cohen HJ, Leach CR, et al. Cancer statistics for adults aged 85 years and older, 2019. CA Cancer J Clin. 2019;69:452\u201367. https:\/\/doi.org\/10.3322\/caac.21577.","journal-title":"CA Cancer J Clin"},{"key":"512_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3322\/caac.21638","volume":"71","author":"MS Sedrak","year":"2021","unstructured":"Sedrak MS, Freedman RA, Cohen HJ, Muss HB, Jatoi A, Klepin HD, et al. Older adult participation in cancer clinical trials: a systematic review of barriers and interventions. CA Cancer J Clin. 2021;71:78\u201392. https:\/\/doi.org\/10.3322\/caac.21638.","journal-title":"CA Cancer J Clin"},{"key":"512_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13690-023-01166-4","volume":"81","author":"J Chang","year":"2023","unstructured":"Chang J, Medina M, Shin DY, Kim SJ. Racial disparity and regional variance in healthcare utilization among patients with lung cancer in US hospitals during 2016\u20132019. Arch Public HEALTH = Arch Belg Sante Publique. 2023;81:150\u20139. https:\/\/doi.org\/10.1186\/s13690-023-01166-4.","journal-title":"Arch Public HEALTH = Arch Belg Sante Publique"},{"key":"512_CR38","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/her\/cyy052","volume":"34","author":"LS Abbott","year":"2019","unstructured":"Abbott LS, Slate EH, Lemacks JL. Influencing cardiovascular health habits in the rural, deep south: results of a cluster randomized trial. Health Educ Res. 2019;34:200\u20138. https:\/\/doi.org\/10.1093\/her\/cyy052.","journal-title":"Health Educ Res"},{"key":"512_CR39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.canep.2017.05.013","volume":"49","author":"JX Moore","year":"2017","unstructured":"Moore JX, Akinyemiju T, Wang HE. Pollution and regional variations of lung cancer mortality in the United States. Cancer Epidemiol. 2017;49:118\u201327. https:\/\/doi.org\/10.1016\/j.canep.2017.05.013.","journal-title":"Cancer Epidemiol"},{"key":"512_CR40","doi-asserted-by":"publisher","first-page":"100615","DOI":"10.1016\/j.currproblcancer.2020.100615","volume":"45","author":"IY Cho","year":"2021","unstructured":"Cho IY, Han K, Shin DW, Park SH, Yoon DW, Shin S, et al. Cardiovascular risk and undertreatment of dyslipidemia in lung cancer survivors: a nationwide population-based study. Curr Probl Cancer. 2021;45:100615. https:\/\/doi.org\/10.1016\/j.currproblcancer.2020.100615.","journal-title":"Curr Probl Cancer"},{"key":"512_CR41","doi-asserted-by":"publisher","first-page":"1491912","DOI":"10.3389\/fcvm.2024.1491912","volume":"11","author":"CS Wang","year":"2024","unstructured":"Wang CS, Wang Z, Yang J, Zhang SB, Zhang PR, Yang Y. Lung cancer and risk of cardiovascular mortality. Front Cardiovasc Med. 2024;11:1491912. https:\/\/doi.org\/10.3389\/fcvm.2024.1491912.","journal-title":"Front Cardiovasc Med"},{"key":"512_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccl.2024.08.005","volume":"43","author":"C Kappel","year":"2025","unstructured":"Kappel C, Tumlinson R, Dent S. Cardiovascular health in breast cancer: survivorship care. Cardiol Clin. 2025;43:69\u201382. https:\/\/doi.org\/10.1016\/j.ccl.2024.08.005.","journal-title":"Cardiol Clin"},{"key":"512_CR43","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/M13-2771","volume":"160","author":"VA Moyer","year":"2014","unstructured":"Moyer VA, U.S. Preventive Services Task Force. Screening for lung cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2014;160:330\u20138. https:\/\/doi.org\/10.7326\/M13-2771.","journal-title":"Ann Intern Med"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-026-00512-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00512-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00512-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:08:42Z","timestamp":1785517722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-026-00512-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["512"],"URL":"https:\/\/doi.org\/10.1186\/s40959-026-00512-z","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As the dataset comprised de-identified public use data, obtaining approval from an institutional review board was deemed unnecessary. The study adhered to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I, along with all co-authors, confirm that this manuscript is original, has not been published before, and is not being reviewed by any other journal. We all approve the submitted version and the authorship as listed. The corresponding author is solely responsible for interacting with the journal throughout the submission and editorial stages.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"97"}}